The vaccine will target triple-negative breast cancer. If approved by the FDA, the vaccine will enter its second stage of the trial this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback